Humana (NYSE:HUM) experienced a 3% price increase last week, which may have been influenced by its recent partnership with Mercy to open new primary care clinics for seniors. This expansion addresses ...

Jefferies analysts lowered the price target on Humana ... analysis. The price target reduction comes as investors are estimating $22-$24 of earnings per share for 2027, putting the stock at ...

Jefferies analysts lowered the price target on Humana (NYSE ... a Hold rating. The stock, currently trading at $231.98 with a market capitalization of $28 billion, is showing signs of being ...

Molina Healthcare provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Shares of Humana Inc. HUM rose 1.39% to $234.96 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.38% to 6,045.26 and the ...

Definitive Healthcare faces structural revenue decline, weak retention, and competitive pressure, raising long-term concerns.

A significant influence on a stock price, at least over the short term, is how a company's quarterly earnings are perceived.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...